Historical record - last NADAC publication: 1/2/2015
Product Information
ZYCLARA 3.75% CREAM is a brand product labeled by Bausch Health US LLC, priced at $36.0836 per EA under NDC 99207027028. Its NADAC has been published 112 times since Nov 28, 2013.
Strength
37.5 mg/g
Manufacturer
Bausch Health US LLCNDC
99207027028
Classification
Brand
Dosage Form
CREAM
Route
TOPICAL
Last Updated
1/2/2015
Active Ingredients
IMIQUIMODApproval Type
New Drug (NDA)
FDA Application
NDA022483On Market Since
11/28/2011
Pharmacological Classes
Price Statistics
The NADAC for ZYCLARA 3.75% CREAM has been published 112 times since Nov 28, 2013, and over the history we have for it it has risen 32.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $36.0836 per EA |
|---|---|
| All-time high | $36.0836 (Jan 13, 2016) |
| All-time low | $27.2844 (Nov 28, 2013) |
| Median price | $31.3770 |
| Average price | $33.3485 |
| Largest weekly change | +15.0% (Jan 15, 2014) |
| Weeks tracked | 112 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the imiquimod market page.
Lowest-Cost Alternatives
No alternatives available
Frequently asked questions
What is the NADAC price of ZYCLARA 3.75% CREAM?
The current National Average Drug Acquisition Cost (NADAC) for ZYCLARA 3.75% CREAM, manufactured by Bausch Health US LLC, is $36.0836 per EA (NDC 99207027028), effective Jan 13, 2016.
How has the price of ZYCLARA 3.75% CREAM changed over time?
Over the history we have for it, the NADAC for ZYCLARA 3.75% CREAM has risen 32.2%. It has been tracked across 112 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for ZYCLARA 3.75% CREAM?
Since Nov 28, 2013, the NADAC for ZYCLARA 3.75% CREAM has ranged from a low of $27.2844 (Nov 28, 2013) to a high of $36.0836 (Jan 13, 2016), with a median of $31.3770 per EA.
Are there cheaper alternatives to ZYCLARA 3.75% CREAM?
No other NADAC-published product currently shares the active ingredient, strength, and dosage form of ZYCLARA 3.75% CREAM, so no direct lower-cost alternative is listed.
Who manufactures ZYCLARA 3.75% CREAM?
ZYCLARA 3.75% CREAM (NDC 99207027028) is labeled by Bausch Health US LLC, and CMS classifies it as a brand product.
Related Drugs
Same classification